| __timestamp | Exelixis, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 50829000 | 1802274 |
| Thursday, January 1, 2015 | 57305000 | 2512761 |
| Friday, January 1, 2016 | 116145000 | 2894488 |
| Sunday, January 1, 2017 | 159362000 | 8096274 |
| Monday, January 1, 2018 | 206366000 | 7985229 |
| Tuesday, January 1, 2019 | 228244000 | 8994597 |
| Wednesday, January 1, 2020 | 293355000 | 29772000 |
| Friday, January 1, 2021 | 401715000 | 33907000 |
| Saturday, January 1, 2022 | 459856000 | 26579000 |
| Sunday, January 1, 2023 | 542705000 | 49868547 |
| Monday, January 1, 2024 | 492128000 |
Data in motion
In the competitive landscape of biopharmaceuticals, effective cost management is crucial. Exelixis, Inc. and Verona Pharma plc, two prominent players, have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses over the past decade.
Exelixis, Inc. has seen a remarkable increase in SG&A expenses, growing nearly tenfold from 2014 to 2023. This surge reflects their aggressive expansion and investment in operational capabilities. In contrast, Verona Pharma plc's SG&A expenses have grown at a more modest pace, increasing by approximately 27 times over the same period. This difference highlights their strategic focus on maintaining lean operations while scaling their business.
Understanding these trends provides valuable insights into each company's strategic priorities and operational efficiencies, offering a window into their future growth potential.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Verona Pharma plc
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Verona Pharma plc
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and Alkermes plc
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and CRISPR Therapeutics AG
Exelixis, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Exelixis, Inc. or Iovance Biotherapeutics, Inc.
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.